ArticleFrontiers in pharmacology2022

Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series.

Yan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.